Rutinib 5mg tablet

Rutinib 5mg (Ruxolitinib) is a prescription medication that is meant for the treatment of certain bone marrow disorders such as myelofibrosis, polycythemia vera, as well as acute graft-versus-host disease (GVHD). It acts as a Janus kinase (JAK) inhibitor, which helps to reduce inflammation and alleviate enlarged spleens among other symptoms associated with diseases.Key InformationDrug Classification: Anti-cancer drug (JAK/Janus Kinase Inhibitor).Uses: Myelofibrosis (MF), Polycythemia Vera (PV), and Steroid-refractory acute or chronic graft-versus-host disease (GVHD).Dosage Formulation: Orally taken. Should be swallowed whole and not crushed or chewed.Adverse Reactions: Reduced number of blood cells (Anemia, Thrombocytopenia, Neutropenia), Increased risk of infections,